<DOC>
	<DOC>NCT01057095</DOC>
	<brief_summary>RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at gene expression in tissue samples from patients with acute myeloid leukemia.</brief_summary>
	<brief_title>Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES: - Screen acute myeloid leukemia (AML) samples to correlate high relative expression levels of PLAGL2 and putative PLAGL2 target genes (implicated in microarray study) with potential pathogenic relevance with respect to AML development. OUTLINE: Cryopreserved mRNA from diagnostic samples is analyzed for gene expression by reverse transcriptase-PCR.</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia, Myeloid</mesh_term>
	<mesh_term>Leukemia, Myeloid, Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Diagnosis of acute myeloid leukemia, including inv(16)(p13;q22) abnormalities No t(15;17)(q22;q12) or t(8;21)(q22;q22) abnormalities PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>adult acute myeloid leukemia with inv(16)(p13;q22)</keyword>
	<keyword>adult acute myeloid leukemia with 11q23 (MLL) abnormalities</keyword>
	<keyword>adult acute myeloid leukemia with del(5q)</keyword>
	<keyword>adult acute myeloid leukemia with t(16;16)(p13;q22)</keyword>
	<keyword>adult acute myeloid leukemia in remission</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>childhood acute myeloid leukemia in remission</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia and other myeloid malignancies</keyword>
</DOC>